Anti-tumor abilities of IL-13 cytotoxins have been shown in vivo, particularly in IL-13Rα2-positive pancreatic cancer cell lines, and also in animal models of human pancreatic cancer [100,108,110]. The gene discussed is IL13; the disease is familial pancreatic carcinoma.